Urolithin A vs Resveratrol: Which Longevity Supplement Should You Choose?

Urolithin A and Resveratrol are both widely discussed in healthy-aging research, but they work through different pathways and have very different clinical evidence. Here’s how they compare.

Reviewed by the Celnovix Editorial Team
Last reviewed: September 2026

Urolithin A and Resveratrol are two of the most discussed compounds in the healthy-aging and longevity space.

Both are associated with cellular health. Both appear frequently in supplement routines. And both are often promoted as ways to support healthier aging.

But they are not interchangeable.

Urolithin A is a gut microbiome-derived metabolite that has attracted particular interest for its relationship with mitophagy, mitochondrial quality control, muscle endurance, and muscle function.

Resveratrol is a plant-derived polyphenol with a much longer research history. It has been studied across areas including oxidative stress, metabolic signaling, inflammation, cardiovascular health, glucose metabolism, and sirtuin-related biology.

So which is better?

The current evidence does not support a universal winner.

The more useful question is:

What has each compound actually been shown to do in humans?


Quick Answer: Urolithin A vs Resveratrol

If you want the short version:

Urolithin A

Human research is more concentrated around:

  • Mitophagy-related biology
  • Mitochondrial quality control
  • Muscle endurance
  • Certain measures of muscle strength
  • Mitochondrial and metabolic biomarkers

Resveratrol

Human research is much broader and includes:

  • Metabolic health
  • Oxidative stress
  • Inflammatory pathways
  • Glucose regulation
  • Cardiovascular outcomes
  • Sirtuin-related signaling
  • Aging-related conditions

However, Resveratrol’s larger research base does not mean its benefits are more conclusively established.

Human trials have produced inconsistent results across many outcomes.

Likewise, Urolithin A has promising human studies, but its evidence base is still relatively small.

Bottom line

Urolithin A currently has a more focused body of research around mitochondrial and muscle-related outcomes. Resveratrol has a much larger but more heterogeneous human evidence base. Neither has been proven to slow human aging or extend lifespan.


What Is Urolithin A?

Urolithin A is a metabolite produced when certain gut microorganisms transform ellagitannins and ellagic acid.

These precursor compounds are found in foods such as:

  • Pomegranates
  • Walnuts
  • Raspberries
  • Strawberries
  • Blackberries

However, not everyone produces the same amount of Urolithin A from food.

Production depends partly on gut microbiome composition.

This variability has contributed to interest in direct Urolithin A supplementation.

Research has focused particularly on its relationship with mitochondrial quality control and mitophagy.

Mitophagy is a cellular process involved in identifying and recycling damaged or dysfunctional mitochondria.

To learn more about natural production, read:

Foods Rich in Urolithin A: Natural Sources and What to Know

For a broader evidence review:

Urolithin A Benefits: What Does the Research Actually Show?


What Is Resveratrol?

Resveratrol is a naturally occurring polyphenol found in foods including:

  • Grapes
  • Red grape skins
  • Blueberries
  • Cranberries
  • Peanuts

It belongs to a class of compounds called stilbenes.

Resveratrol became especially prominent in aging research because laboratory and animal studies suggested effects involving:

  • Oxidative stress
  • Inflammatory signaling
  • AMPK
  • Sirtuins
  • Mitochondrial biology
  • Glucose metabolism
  • Vascular function

This generated enormous interest in Resveratrol as a potential longevity compound.

But human evidence has been considerably more complicated than many early headlines suggested.

A large systematic review of clinical trials published in 2024 concluded that, despite nearly 200 studies across more than 20 clinical areas, there was still no conclusive clinical evidence supporting Resveratrol as a standard treatment for any particular health condition.

Read the systematic review on PubMed


Urolithin A vs Resveratrol: The Main Difference

The simplest comparison is:

Urolithin A research is more concentrated around mitochondrial quality control.

Resveratrol research spans a wider range of metabolic and cellular signaling pathways.

But this should not be reduced to:

Urolithin A = mitochondria
Resveratrol = antioxidant

That is too simplistic.

Resveratrol has also been investigated in mitochondrial biology.

Urolithin A also influences biological systems beyond a single mitochondrial pathway.

The compounds overlap in some areas of aging biology, but their origins, mechanisms, and research histories are different.


Urolithin A vs Resveratrol: Side-by-Side Comparison

Feature

Urolithin A

Resveratrol

Compound type

Gut microbiome-derived metabolite

Plant polyphenol

Dietary origin

Ellagitannins and ellagic acid

Grapes, berries, peanuts

Major research focus

Mitophagy and mitochondrial quality control

Metabolic signaling, oxidative stress, inflammation

Human research history

Relatively recent

More than two decades

Human RCTs

Several

Many

Muscle research

Significant focus

Studied, but less central

Mitochondrial research

Central research area

Also investigated

Sirtuin research

Not defining mechanism

Frequently studied

Proven to extend lifespan?

No

No

Proven anti-aging treatment?

No

No

Direct UA vs Resveratrol trial?

No established high-quality head-to-head trial

No

Combination proven superior?

No

No

The table highlights an important point:

Research quantity and research certainty are not the same thing.

Resveratrol has been studied more extensively, but many findings remain inconsistent.


Which Has Better Evidence for Mitochondrial Health?

This is one area where Urolithin A has a relatively clear research identity.

A first-in-human trial published in Nature Metabolism found that Urolithin A was bioavailable and influenced molecular signatures associated with mitochondrial and cellular metabolism.

Read the Nature Metabolism study

Later randomized trials investigated:

  • Muscle endurance
  • Muscle strength
  • ATP-related measurements
  • Mitochondrial biomarkers
  • Physical performance

The overall picture is promising but mixed.

For example, some endurance and strength outcomes improved, while several primary endpoints did not significantly outperform placebo.

Read our full evidence breakdown:

Urolithin A Benefits: What Does the Research Actually Show?

What about Resveratrol?

Resveratrol also interacts with pathways involved in mitochondrial and energy metabolism, including AMPK- and sirtuin-related pathways.

However, clinical outcomes vary considerably according to:

  • Population
  • Dose
  • Duration
  • Disease status
  • Endpoint
  • Study design

There is currently no high-quality direct clinical trial proving that Urolithin A is superior to Resveratrol for mitochondrial health.

Verdict

Urolithin A has a more focused human research program around mitochondrial quality control, but superiority over Resveratrol has not been established.


Which Has Better Evidence for Muscle Health?

Urolithin A currently has several notable randomized human trials specifically evaluating muscle-related outcomes.

A 2022 trial in older adults investigated 1,000 mg per day for four months.

Researchers found improvements in some muscle-endurance measurements and mitochondrial-related biomarkers.

However, the primary outcomes involving 6-minute walking distance and maximal ATP production did not significantly improve versus placebo.

Read the JAMA Network Open trial

Another randomized trial in middle-aged adults investigated 500 mg and 1,000 mg daily.

Some measures of muscle strength improved, particularly hamstring strength, while other outcomes were less consistent.

Read the Cell Reports Medicine trial

Resveratrol and muscle health

Resveratrol has also been studied in older adults and populations with physical limitations.

A 2024 systematic review examining Resveratrol supplementation in older adults found mixed findings across physical function, metabolic conditions, and neurological outcomes. The authors concluded that optimal dosage, long-term effects, and medication interactions remain insufficiently established.

Read the 2024 review on PubMed

Verdict

For a supplement specifically being researched around mitochondrial muscle biology, Urolithin A currently has a clearer research focus. But neither compound is established as a treatment for age-related muscle loss or physical decline.


Which Is Better for SIRT1?

Resveratrol is frequently described online as a SIRT1 activator.

This idea comes largely from mechanistic and preclinical research.

But recent human evidence is more complicated.

A 2025 systematic review and meta-analysis included 11 randomized controlled trials evaluating Resveratrol and human SIRT1 measures.

The overall analysis found no significant effect on:

  • SIRT1 gene expression
  • SIRT1 protein expression
  • Serum SIRT1 levels

Some subgroup and dose-response analyses suggested that effects may depend on dose, duration, and tissue measured.

But the overall result was not significant.

Read the 2025 SIRT1 meta-analysis on PubMed

This is a good example of why a mechanism discussed in laboratory research should not automatically become a consumer claim.

Verdict

Resveratrol remains scientifically relevant to sirtuin research, but saying that Resveratrol reliably “activates SIRT1 in humans” oversimplifies current clinical evidence.


Which Has Better Anti-Aging Evidence?

Neither.

This may sound surprising because both ingredients are heavily marketed around longevity.

But neither Urolithin A nor Resveratrol has been proven in high-quality human trials to:

  • Reverse aging
  • Slow overall biological aging
  • Extend human lifespan
  • Prevent age-related disease broadly
  • Increase healthspan in a clinically established way

Researchers study both compounds because they affect pathways relevant to aging biology.

That is not the same as proving an anti-aging effect.

Urolithin A

The strongest evidence involves mitochondrial and muscle-related outcomes.

Resveratrol

The research base covers many aging-associated biological systems, but clinical outcomes remain heterogeneous.

A comprehensive review of Resveratrol clinical trials concluded that evidence was not sufficient to recommend it clinically for any particular healthcare indication. (pubmed.ncbi.nlm.nih.gov)

Verdict

Neither is a proven anti-aging therapy.


Which Is Better for Cellular Energy?

This question requires careful wording.

Urolithin A

Research focuses partly on mitochondrial quality control and cellular metabolism.

But Urolithin A is not an acute stimulant and has not been proven to produce an immediate subjective energy boost.

Resveratrol

Resveratrol has been investigated in pathways involved in cellular energy sensing and metabolism, including AMPK and sirtuin-related biology.

Again, this does not mean taking Resveratrol produces immediate “cellular energy.”

Verdict

Neither compound should be treated like caffeine or a conventional energy supplement.


Which Is Better for Cardiovascular Health?

Resveratrol has a much larger cardiovascular research history than Urolithin A.

Human studies have examined outcomes including:

  • Blood pressure
  • Endothelial function
  • Lipid markers
  • Glucose metabolism
  • Inflammatory biomarkers

But results differ according to population and study design.

An umbrella review published in 2026 analyzed existing systematic reviews and meta-analyses of randomized controlled trials across multiple Resveratrol-related health outcomes.

The review included 45 systematic reviews covering 68 health outcomes, illustrating both the size and complexity of the evidence base.

View the umbrella review on PubMed

This breadth of research should not be confused with universal clinical benefit.

Urolithin A

Urolithin A has not been studied nearly as extensively for cardiovascular outcomes.

Verdict

Resveratrol has substantially more cardiovascular research, but neither supplement should be considered a proven substitute for evidence-based cardiovascular prevention or treatment.


Which Is Better for Metabolic Health?

Resveratrol has been much more extensively studied in:

  • Insulin sensitivity
  • Glucose regulation
  • Metabolic syndrome
  • Obesity
  • Type 2 diabetes
  • Lipid metabolism

But once again, results are inconsistent.

Different trials use different:

  • Doses
  • Populations
  • Treatment durations
  • Baseline metabolic states

That makes broad claims difficult.

Urolithin A studies have reported changes in certain metabolic biomarkers, including acylcarnitines and other mitochondrial-associated markers, but metabolic disease is not currently the central area of its clinical evidence.

Verdict

Resveratrol has more human metabolic research, but the evidence does not justify calling it a universally effective metabolic treatment.


Which Has More Human Research?

Resveratrol, by a large margin.

A 2024 systematic review reported that nearly 200 clinical studies had examined purified Resveratrol across at least 24 health indications over approximately two decades. (pubmed.ncbi.nlm.nih.gov)

Urolithin A is a much newer research area.

A 2024 Urolithin A systematic review identified five human studies involving approximately 250 healthy participants.

View the Urolithin A systematic review on PubMed

But again:

More studies do not necessarily mean more certainty.

Resveratrol has been studied much more widely, yet major uncertainty remains around:

  • Optimal dose
  • Target population
  • Long-term use
  • Clinically meaningful outcomes
  • Drug interactions
  • Which individuals may actually benefit

Urolithin A vs Resveratrol: Which Has Stronger Evidence?

The fairest answer depends on what you mean by “stronger.”

Urolithin A

Strengths

  • Focused biological rationale
  • Multiple randomized human trials
  • Mitochondrial and muscle-related endpoints
  • More standardized recent clinical programs

Limitations

  • Small overall evidence base
  • Relatively small trial populations
  • Short study duration
  • Several outcomes remain inconclusive

Resveratrol

Strengths

  • Much larger human evidence base
  • Many randomized trials
  • Studied across numerous physiological systems
  • Long history of clinical investigation

Limitations

  • Highly heterogeneous results
  • Wide dose variation
  • Variable bioavailability
  • No accepted optimal dosing regimen
  • No established anti-aging indication

So asking which one has “better science” does not have a simple answer.


Urolithin A vs Resveratrol Bioavailability

Bioavailability is another major difference.

Resveratrol is absorbed from the gastrointestinal tract but undergoes rapid metabolism.

This has created long-standing questions about how much unchanged Resveratrol reaches systemic tissues and how circulating metabolites contribute to biological effects.

This issue helps explain why strong findings in laboratory models do not always translate cleanly into human trials.

Urolithin A also undergoes metabolism after absorption, including conjugation, but human pharmacokinetic studies have demonstrated systemic exposure following oral supplementation.

These pharmacokinetic differences make direct milligram-to-milligram comparisons meaningless.

500 mg of one compound cannot be directly compared with 500 mg of another simply by looking at the label.


Urolithin A vs Resveratrol Dosage

There is no useful direct dosage conversion between the two.

Urolithin A

Human trials have investigated doses including:

  • 500 mg/day
  • 1,000 mg/day

among other doses.

Read:

Urolithin A Dosage Guide: How Much Should You Take?

Resveratrol

Clinical studies have used a very wide range of doses.

A comprehensive review of Resveratrol trials noted substantial variation between studies and no consensus therapeutic regimen for specific outcomes.

Therefore:

Clinical-trial doses should not automatically be interpreted as personal dosage recommendations.


Can You Take Urolithin A and Resveratrol Together?

This is where the original version of this article needed the biggest correction.

You will often see claims that:

“Urolithin A and Resveratrol work through different pathways, so taking them together gives broader longevity support.”

The first half may be biologically reasonable.

The second half has not been clinically established.

There is currently insufficient high-quality human evidence showing that combining Urolithin A and Resveratrol produces better health outcomes than either compound alone.

Established clinical evidence does not currently include robust randomized trials directly comparing:

  • Urolithin A alone
  • Resveratrol alone
  • Urolithin A + Resveratrol
  • Placebo

Therefore:

Theoretical complementarity should not be confused with demonstrated clinical synergy.

If you take medications, have a diagnosed health condition, or use multiple supplements, discuss combinations with an appropriately qualified healthcare professional.


What About NMN + Urolithin A + Resveratrol?

This combination is frequently referred to as a “longevity stack.”

Mechanistically, the three compounds are different:

NMN

Associated with NAD+ metabolism.

Urolithin A

Associated with mitochondrial quality control and mitophagy-related biology.

Resveratrol

Associated with polyphenol biology, metabolic signaling, oxidative stress, and sirtuin-related research.

This may look attractive on paper.

But there is currently insufficient randomized human evidence demonstrating that taking all three together produces superior health or longevity outcomes.

A sophisticated-looking pathway diagram is not the same thing as a clinical trial.

If you’re interested specifically in NMN and Urolithin A, read:

Can You Take NMN and Urolithin A Together?

And:

NMN vs Urolithin A: Which Longevity Supplement Should You Choose?


Urolithin A vs Resveratrol for Healthy Aging

If you’re evaluating these compounds purely from a healthy-aging perspective, it may help to stop thinking in terms of:

Which supplement is better?

and instead ask:

What is the actual human evidence behind the outcome I care about?

For example:

Interested in mitochondrial quality control?

Urolithin A has a focused research program in this area.

Interested in polyphenol and metabolic research?

Resveratrol has a much broader literature.

Interested in muscle endurance?

Urolithin A has several dedicated human trials.

Interested in cardiovascular or glucose-related research?

Resveratrol has been studied more extensively.

Interested in living longer?

Neither compound has been proven to extend human lifespan.

This is a more useful framework than trying to declare one universal winner.


Should You Choose Urolithin A or Resveratrol?

There is no evidence-based recommendation that applies to everyone.

From a research perspective:

Urolithin A may be more relevant if you’re reading research about:

  • Mitophagy
  • Mitochondrial quality control
  • Muscle endurance
  • Muscle-related aging
  • Mitochondrial biomarkers

Resveratrol may be more relevant if you’re reading research about:

  • Polyphenols
  • Oxidative stress
  • Metabolic signaling
  • Glucose regulation
  • Cardiovascular markers
  • Sirtuin-related biology

But these categories overlap.

And neither compound is a substitute for:

  • Exercise
  • Good nutrition
  • Adequate sleep
  • Resistance training
  • Weight management when appropriate
  • Avoiding smoking
  • Preventive healthcare
  • Evidence-based treatment of medical conditions

What Matters More Than Either Supplement?

Healthy aging is not driven by one molecule.

The strongest interventions remain much less glamorous:

  • Regular physical activity
  • Resistance training
  • Maintaining cardiorespiratory fitness
  • Adequate protein and overall nutrition
  • Sufficient sleep
  • Healthy blood pressure
  • Healthy glucose regulation
  • Appropriate lipid management
  • Avoiding tobacco
  • Limiting excessive alcohol
  • Maintaining social engagement
  • Receiving appropriate preventive medical care

Supplements may eventually have useful complementary roles.

They should not replace the fundamentals.


The Bottom Line

So, Urolithin A vs Resveratrol—which is better?

There is no universal winner.

Urolithin A has a newer, more focused research base centered largely on:

  • Mitophagy
  • Mitochondrial quality control
  • Muscle endurance
  • Certain muscle-strength outcomes
  • Mitochondrial biomarkers

Resveratrol has a much larger and longer research history involving:

  • Metabolic signaling
  • Oxidative stress
  • Inflammation
  • Cardiovascular biology
  • Glucose metabolism
  • Sirtuin-related pathways

But neither has been proven to:

  • Reverse aging
  • Extend human lifespan
  • Prevent age-related disease broadly
  • Work better than established healthy lifestyle interventions

There is also insufficient evidence showing that combining the two produces additional clinical benefit.

The most scientifically responsible conclusion is therefore:

They are different compounds with different research profiles—not competing versions of the same supplement.


Frequently Asked Questions

Is Urolithin A better than Resveratrol?

Current human evidence does not establish Urolithin A as universally better than Resveratrol. Urolithin A research is more focused on mitochondrial quality control and muscle-related outcomes, while Resveratrol has a broader but more heterogeneous research history.

Does Resveratrol have more research than Urolithin A?

Yes. Resveratrol has been studied in substantially more human clinical trials. However, the larger evidence base has produced mixed results and has not established Resveratrol as a proven anti-aging treatment.

Which is better for mitochondrial health?

Urolithin A has been studied specifically around mitophagy and mitochondrial biomarkers. Resveratrol also affects pathways associated with mitochondrial metabolism. There is no high-quality head-to-head clinical trial proving one is superior.

Which is better for muscle health?

Urolithin A has several dedicated human randomized trials investigating muscle endurance and strength. Resveratrol has also been studied in older adults and muscle-related contexts, but the evidence varies between populations.

Which is better for longevity?

Neither has been proven to extend human lifespan or broadly slow human aging.

Does Resveratrol activate SIRT1?

Resveratrol is strongly associated with SIRT1 in preclinical research. However, a 2025 meta-analysis of randomized human trials found no significant overall effect on SIRT1 gene expression, protein expression, or serum levels.

Can I take Urolithin A and Resveratrol together?

There is currently insufficient high-quality clinical evidence showing that the combination produces better outcomes than either compound alone.

Can I take NMN, Urolithin A, and Resveratrol together?

There is insufficient randomized human evidence demonstrating that combining all three improves healthy-aging outcomes. People using medications or managing medical conditions should discuss multi-supplement routines with a healthcare professional.

Is Resveratrol an antioxidant?

Resveratrol has antioxidant-related biological activity, but describing it only as an “antioxidant supplement” oversimplifies its biology and research history.

Which has better clinical evidence?

It depends on the outcome. Resveratrol has far more clinical studies overall, while Urolithin A has a smaller but more focused body of human research around mitochondrial and muscle-related outcomes.


Related Celnovix Guides


References

Andreux PA, Blanco-Bose W, Ryu D, et al.

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans.
Nature Metabolism. 2019;1:595–603.

Read the original study in Nature Metabolism


Liu S, D’Amico D, Shankland E, et al.

Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial.
JAMA Network Open. 2022;5(1):e2144279.

Read the clinical trial

View on PubMed


Singh A, D’Amico D, Andreux PA, et al.

Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults.
Cell Reports Medicine. 2022;3(5):100633.

Read the full study

View on PubMed


Targeting Aging With Urolithin A in Humans: A Systematic Review

This 2024 systematic review evaluated five human studies and summarized evidence across mitochondrial, inflammatory, muscle, endurance, and physical-function outcomes.

View the systematic review on PubMed


Resveratrol for the Management of Human Health: How Far Have We Come?

This systematic review evaluated the clinical Resveratrol literature across nearly 200 studies and more than 20 clinical areas. The authors concluded that conclusive evidence supporting routine clinical recommendation remains lacking.

View the systematic review on PubMed


Mansouri F, Feliziani G, Bordoni L, Gabbianelli R.

Impact of Resveratrol Supplementation on Human Sirtuin 1: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.
Journal of the Academy of Nutrition and Dietetics. 2025.

The meta-analysis included 11 randomized controlled trials and found no significant overall effect of Resveratrol on human SIRT1 gene expression, protein expression, or serum levels.

View the meta-analysis on PubMed


Effects and Safety of Resveratrol Supplementation in Older Adults: A Comprehensive Systematic Review

This review included randomized clinical studies in older adults and reported mixed findings across physical, metabolic, and neurological outcomes while emphasizing uncertainty around optimal dose, long-term effects, and medication interactions.

View the review on PubMed


Effects of Resveratrol Supplementation on Multiple Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses of Randomized Controlled Trials

This large umbrella review assessed 45 systematic reviews covering 68 human health outcomes, highlighting the breadth of Resveratrol research as well as substantial variability in evidence quality and clinical effects.

View the umbrella review on PubMed


Editorial Standards

Celnovix publishes evidence-informed educational content about healthy aging, nutrition, supplementation, and emerging longevity research.

When comparing supplements, we aim to distinguish between:

  • Human randomized clinical outcomes
  • Systematic reviews and meta-analyses
  • Biomarker findings
  • Mechanistic research
  • Animal or laboratory findings
  • Theoretical supplement combinations
  • Marketing claims

A biological mechanism alone is not considered proof of clinical benefit.

Articles are periodically reviewed as meaningful new human evidence becomes available.


Medical Disclaimer

This article is provided for general educational and informational purposes only and is not intended as medical advice, diagnosis, prevention, or treatment.

Dietary supplements are not intended to diagnose, treat, cure, or prevent disease.

Clinical-study findings may not apply to every individual, dose, population, supplement combination, or commercial formulation.

Resveratrol and other supplements may interact with medications or may not be appropriate for certain individuals. If you have a medical condition, take prescription or over-the-counter medications, are pregnant or breastfeeding, are preparing for surgery, or are considering multiple supplements, consult an appropriately qualified healthcare professional before changing your routine.

Behind Our 2026 Supplement Selections

Zurück zum Blog

Hinterlasse einen Kommentar

Bitte beachte, dass Kommentare vor der Veröffentlichung freigegeben werden müssen.